Synjardy

Active Ingredient(s): Empagliflozin + Metformin Hydrochloride
FDA Approved: * August 26, 2015
Pharm Company: * BOEHRINGER INGELHEIM
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Synjardy Overview

Empagliflozin, sold under the brand name Jardiance among others, is a medication used together with diet and exercise to treat type 2 diabetes.[2][7] It can be prescribed instead of metformin and has benefits over sulfonylureas.[8] It may be used together with other medications such as metformin or insulin.[2][7] It is not recommended for type 1 diabetes.[2] It is taken by mouth.[2]...

Read more Synjardy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Empagliflozin

Recent Synjardy Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Empagliflozin + Metformin Hydrochloride
  • Tablet: 12.5mg + 1gm, 12.5mg + 500mg, 12.5mg/1000mg, 12.5mg/500mg, 5mg + 1gm, 5mg + 500mg, 5mg/1000mg, 5mg/500mg
  • Tablet, Extended Release: 10mg + 1gm, 12.5mg + 1gm, 25mg + 1gm, 25mg + 2000mg, 5mg + 1gm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Synjardy: (4 results)

Sorted by National Drug Code
  • 0597-0159 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0168 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0175 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0180 Synjardy Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (31 results)